Skip to content

AnaptysBio, Inc. ANAB Customer receivables and Other

Customer receivables and Other at other companies

Morgan Stanley logo
Morgan StanleyMS
$2.52B+0.4%
Raymond James Financial logo
Raymond James FinancialRJF
$1.81B-3.5%
Chicago Atlantic Real Estate Finance logo
Chicago Atlantic Real Estate FinanceREFI
$2.56M+388%
Customers Bancorp logo
Customers BancorpCUBI
$2.37M+25.7%
Arbor Realty Trust logo
Arbor Realty TrustABR
$35.25M+267%
Ares Management Corporation logo
Ares Management CorporationARES
$0-100%

Segments

By segment

See full
Biopharma Company$2.33M
Royalty Management Company$325K

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.7B+180%

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeOther.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s customer receivables and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s customer receivables and other?
AnaptysBio, Inc. (ANAB) reported customer receivables and other of $2.65M in Q1 2026.
How has AnaptysBio, Inc.'s customer receivables and other changed year-over-year?
AnaptysBio, Inc.'s customer receivables and other decreased by 39.9% year-over-year, from $4.41M to $2.65M.
What is the long-term trend for AnaptysBio, Inc.'s customer receivables and other?
Over 4 years (2021 to 2025), AnaptysBio, Inc.'s customer receivables and other has grown at a 136.6% compound annual growth rate (CAGR), from $431K to $13.5M.